Navigation Links
Cancer/Tumor Profiling Market (Personalized Medicine, Biomarker Discovery, Prognosis, Research) Worth $35.03 Billion by 2018 – New Report by MarketsandMarkets
Date:9/30/2013

(PRWEB) September 30, 2013

The "Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018" report analyzes and studies the major market drivers, restraints, and adoption potential in North America, Europe, Asia, and Rest of the World.

Browse market 22 data tables and 50 Figures and spread through 173 slides and in-depth TOC on Cancer/Tumor Profiling Market:
http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html

Early buyers will receive 10% customization on this report.

This report studies the global cancer/tumor profiling market, with forecast to 2018.

The global healthcare industry is witnessing a paradigm shift, skewed towards point-of-care diagnostics, cost-effective treatment modalities, and personalized medicine, which not only offers efficient early diagnosis, but also treats cancer conditions in order to reduce the healthcare cost and disease burden. Cancer/Tumor profiling is one such technology with the exact potential to revolutionize cancer diagnostics and therapeutics in the healthcare industry.

This market research report evaluates the global market of cancer/tumor profiling by geography, applications, technologies, and segment types. Further, the applications market is divided into five segments, namely Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis and Research Applications; the technologies section is divided into five segments, namely Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray; and finally, the segment types is partitione
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. First prospective trial shows molecular profiling timely for tailoring therapy
2. North America Leads Cancer Tumor Profiling Market 2018 Forecasts in a New Research Report at RnRMarketResearch.com
3. Majority of states fail to address youth exposure to alcohol marketing
4. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
5. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
6. New Report Video Surveillance Market (2011 – 2016) by MarketsandMarkets
7. Dotcomsecrets is Offering New Opportunities to People Who Want to Become Expert in Localized Internet Marketing
8. 101 Mobility Opens Franchise in Roanoke/Lynchburg Market
9. How MyTownInsurance.com Helps Insurance Carriers Manage their Loss Exposure through On-Line Marketing
10. Discount Supermarkets Tied to Rising Obesity Rates
11. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 02, 2015 Join us for a new ... in Honor of Rhonda Martin , who overcame her brain ... dedicated their resources to raising awareness and funds for brain ... awareness in hopes that there will be one less case ... welcome and encouraged to join the 1st Anniversary Awareness ...
(Date:6/2/2015)... 2015 Pacifica Graduate Institute ... by current and former students to honor the memory ... from 2002 until his death in 2013. His students ... of feeling, as well as his passion for politics, ... an analyst, teacher, and writer were felt in his ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “We want men ... ultraviolet (UV) sun rays”, states Marta Phillips, owner of SunGrubbies.com, ... men’s sun hats and sun accessories that work well for ... not immediately evident. Sometimes sun damage can take up to ... neck are prime areas for skin cancer to occur. ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lynn Lester as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... Lester with this prestigious award,” said NAPW President Star ...
(Date:6/1/2015)... June 02, 2015 The National ... Ditmyer as a 2015-2016 inductee into the NAPW ... recognized with this prestigious distinction for leadership in academics. ... Local Chapters, NAPW is the nation’s leading networking organization ... Marcia with this important distinction,” said NAPW President Star ...
Breaking Medicine News(10 mins):Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2
... Researchers from Japan have recently demonstrated the first evidence ... ,Fungal secondary metabolites such as gliotoxin, an ... Aspergillus//, possess immunosuppressive activities and have been thought to ... humans. ,Mast cells play a key role ...
... who are prone to backaches, insomnia and eyesight problems ... treatment protocol for treating software professionals would be outlined ... Thrissur next month, said eminent ayurveda expert Neelakantan Mooss ... Thaikkattu Mooss Vaidyaratnam Oushadhasala, said detailed examinations had been ...
... from National Cancer Institute, US is to start testing their ... drug metabolize, enzyme kinetics and drug action mechanisms in dogs ... ,Dr. Chand Khanna, Veterinary Oncologist said, “It turns out that ... represented in dogs and the dogs will help us prioritize ...
... new research conducted in Helsinki, Finland, gluten-free diet ... adolescents with coeliac disease.,Coeliac disease in adolescents has ... and disruptive behavioural disorders, particularly in the phase ... 9 adolescents with coeliac disease, aged 12 to ...
... the first of its kind, French researchers report of ... with attention-deficit/hyperactivity disorder//. , The authors, ... present the case report of a 3-year-old child, who ... and sleep problems. ,According to the parents, ...
... is expected to get a major boost with the central ... in the interior regions//. ,Health Minister Anbumani ... northeastern states in Assam's main city of Guwahati with a ... adequate nursing staff. ,"We shall make it mandatory for ...
Cached Medicine News:Health News:Gluten-Free Diet May Alleviate Psychiatric Symptoms In Adolescents 2Health News:Iron Supplementation Aid In Relief From Attention-Deficit/Hyperactivity Disorder 2
(Date:6/1/2015)... Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" ... developing and commercializing proven cancer therapies in new ... from its Phase I/II clinical trial of  VAL-083 ... the most common and deadly form of human ...
(Date:6/1/2015)... LONDON , June 1, 2015 ... carcinoma segment will drive growth , says   ... Cell Lung Cancer (NSCLC) treatment market will be driven primarily ... and squamous cell treatment settings, which either replace or combine ... GBI Research - Non-Small Cell Lung Cancer Market to ...
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global Power Wheelchair ... The Global Power Wheelchair Industry Report ... the current state of the power wheelchair industry. ... of the industry including definitions, classifications, applications and ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3Global Power Wheelchair Industry Trends 2015-2020 2
... 2011 Alere Inc. (NYSE: ALR ), ... health at home through the merger of rapid diagnostics and health ... 31, 2010. Financial results for the fourth quarter ... the fourth quarter of 2010, compared to $546.2 million for the ...
... 2011 Cepheid (Nasdaq: CPHD ) today ... following investor conferences, and invited investors to participate via ... 1, 2011 at 8.30 a.m. Eastern TimeRBC Capital Markets, ... 11.00 a.m. Eastern TimeTo access the live webcasts for ...
Cached Medicine Technology:Alere Inc. Announces Fourth Quarter 2010 Results 2Alere Inc. Announces Fourth Quarter 2010 Results 3Alere Inc. Announces Fourth Quarter 2010 Results 4Alere Inc. Announces Fourth Quarter 2010 Results 5Alere Inc. Announces Fourth Quarter 2010 Results 6Alere Inc. Announces Fourth Quarter 2010 Results 7Alere Inc. Announces Fourth Quarter 2010 Results 8Alere Inc. Announces Fourth Quarter 2010 Results 9Alere Inc. Announces Fourth Quarter 2010 Results 10Alere Inc. Announces Fourth Quarter 2010 Results 11Alere Inc. Announces Fourth Quarter 2010 Results 12Alere Inc. Announces Fourth Quarter 2010 Results 13Alere Inc. Announces Fourth Quarter 2010 Results 14Alere Inc. Announces Fourth Quarter 2010 Results 15Alere Inc. Announces Fourth Quarter 2010 Results 16Alere Inc. Announces Fourth Quarter 2010 Results 17Alere Inc. Announces Fourth Quarter 2010 Results 18Alere Inc. Announces Fourth Quarter 2010 Results 19Cepheid to Webcast Upcoming Financial Presentations 2
... ACL 8000 is an easy-to-use, automated system ... array of assays for managing hemostatic disordersincluding ... S. Also offers reflex and rerun testing ... it's backed by our high-quality service to ...
... System is designed to provide excellent capture ... carotid stenting interventions. The ACCUNET is a ... utilizes rapid exchange technology so that the ... catheter manipulations. It is available in both ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
Medicine Products: